| Hang Seng Index | 23.920 HKD | +0.280 | +1.184% | 286.71M | 6.84B | 23.260 (+2.838%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.030 HKD | +0.038 | +0.761% | 1.03B | 5.18B | 5.580 (-9.860%) HKD as at 2025/02/25 | | |
| Hang Seng China Enterprises | 88.220 HKD | +1.160 | +1.332% | 53.48M | 4.69B | 86.975 (+1.431%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng TECH Index | 4.752 HKD | +0.044 | +0.935% | 150.23M | 715.02M | 6.590 (-27.891%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng TECH Index | 1.854 HKD | -0.030 | -1.592% | 305.45M | 568.42M | 1.831 (+1.234%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 2.334 HKD | -0.054 | -2.261% | 107.28M | 251.83M | 2.726 (-14.377%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng Index | 5.035 HKD | +0.113 | +2.296% | 36.89M | 184.71M | 5.000 (+0.706%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 10.760 HKD | +0.040 | +0.373% | 12.03M | 129.53M | 12.133 (-11.314%) HKD as at 2025/02/24 | | |
| HSI ESG Enhanced Index (net total return index) | 49.060 HKD | +0.280 | +0.574% | 2.52M | 123.73M | 47.751 (+2.741%) HKD as at 2025/02/25 | | |
| CSI 300 | 43.500 HKD | +0.040 | +0.092% | 1.88M | 81.89M | 43.473 (+0.062%) HKD as at 2025/02/25 | | |
| Hang Seng TECH Index | 5.100 HKD | +0.025 | +0.493% | 13.88M | 70.78M | 5.659 (-9.870%) HKD as at 2025/02/25 | | |
| FTSE China A50 | 14.100 HKD | +0.090 | +0.642% | 3.48M | 48.98M | 13.749 (+2.553%) HKD as at 2025/02/24 | | |
| Hang Seng China Enterprises | 10.500 HKD | +0.070 | +0.671% | 4.66M | 48.86M | 10.808 (-2.852%) HKD as at 2025/02/24 | | |
| London Gold Fixing Price | 2,422.000 HKD | -2.000 | -0.083% | 17.70K | 42.88M | N/A | | |
| FTSE China A50 | 13.140 HKD | +0.060 | +0.459% | 1.92M | 25.23M | 12.681 (+3.617%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | NASDAQ-100 Index | 4.390 HKD | -0.056 | -1.260% | 5.02M | 22.11M | 4.925 (-10.868%) HKD as at 2025/02/24 | | |
| Hang Seng High Dividend Yield | 27.440 HKD | +0.180 | +0.660% | 736.11K | 20.12M | 24.714 (+11.030%) HKD as at 2025/02/24 | | |
| MSCI Asia APEX 50 | 61.140 HKD | +0.680 | +1.125% | 285.26K | 17.40M | 57.370 (+6.572%) HKD as at 2025/02/24 | | |
| CSI 300 | 39.860 CNY | +0.080 | +0.201% | 355.80K | 14.19M | 40.598 (-1.819%) CNY as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Solactive Gold 1-Day Rolling Futures Index | 17.220 HKD | -0.200 | -1.148% | 774.60K | 13.34M | 13.980 (+23.179%) HKD as at 2025/02/24 | | |
| MSCI China | 23.800 HKD | +0.200 | +0.847% | 479.63K | 11.40M | 23.954 (-0.644%) HKD as at 2025/02/24 | | |
| FTSE China A50 | 12.900 CNY | +0.060 | +0.467% | 670.00K | 8.63M | 12.820 (+0.625%) CNY as at 2025/02/24 | | |
| S&P GSCI Crude Oil Index Excess Return | 7.285 HKD | -0.015 | -0.205% | 1.11M | 8.06M | 6.880 (+5.894%) HKD as at 2025/02/24 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | Hang Seng China Enterprises | 3.126 HKD | +0.064 | +2.090% | 2.01M | 6.27M | 3.260 (-4.096%) HKD as at 2025/02/25 | | |
-1x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Hang Seng Index | 3.856 HKD | -0.038 | -0.976% | 1.41M | 5.46M | 4.098 (-5.915%) HKD as at 2025/02/25 | | |
| Hang Seng Index | 21.840 CNY | +0.180 | +0.831% | 242.00K | 5.29M | 21.745 (+0.437%) CNY as at 2025/02/25 | | |
| Hang Seng Hong Kong-Listed Biotech Index | 12.950 HKD | -0.020 | -0.154% | 381.88K | 4.95M | 10.297 (+25.762%) HKD as at 2025/02/25 | | |
-2x Inverse Products typically aim to deliver the opposite of the daily return of the underlying index that they track. Inverse Products seeking SFC authorisation shall be subject to a maximum leverage factor of one time (-1x); Inverse Products cannot be leveraged. | Nikkei Stock Average Index | 60.580 HKD | +0.120 | +0.198% | 73.84K | 4.48M | 67.238 (-9.902%) HKD as at 2025/02/25 | | |
+2x Leveraged Products typically aim to deliver a daily return equivalent to a multiple of the underlying index return that they track. Leveraged Products seeking SFC authorisation shall be subject to a maximum leverage factor of two times (2x). | ChiNext Index (HKD)(CNH) | 3.292 HKD | -0.060 | -1.790% | 1.22M | 4.06M | 4.284 (-23.160%) HKD as at 2025/02/24 | | |
| Hong Kong Interbank Offered Rate | 1,159.500 HKD | -0.150 | -0.013% | 3.47K | 4.02M | 1,148.525 (+0.956%) HKD as at 2025/02/25 | | |